Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)
China flag China · Delayed Price · Currency is CNY
20.01
-0.22 (-1.09%)
At close: Nov 17, 2026

SHA:688739 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,3381,3901,6761,7501,8152,088
Revenue Growth
-8.97%-17.06%-4.22%-3.58%-13.08%4.63%
Cost of Revenue
428.64405.79319.24342.56243.28220.37
Gross Profit
909984.51,3571,4081,5721,868
Selling, General & Admin
638.55610.49659.02648.29588.41603.58
Research & Development
240.57292.93281.94219.96210.89236.82
Other Operating Expenses
24.615.2822.5721.8622.120.82
Operating Expenses
904.73927.14972.19902.89836.49877.65
Operating Income
4.2757.36384.8504.66735.23990.02
Interest Expense
-1.27-1.43-1.58-1.42-1.32-1.54
Interest & Investment Income
37.1853.1170.596.81128.345.81
Currency Exchange Gain (Loss)
0.420.420.842.472.5-0.48
Other Non Operating Income (Expenses)
-5.38-2.06-0.28-0.82-0.47-0.42
EBT Excluding Unusual Items
35.22107.41454.28601.71864.251,033
Gain (Loss) on Sale of Investments
47.9151.43-75.57-45.29-43.63-25.53
Gain (Loss) on Sale of Assets
-0.54-0.51-1.721.61-0.79-0.69
Asset Writedown
7.04-----
Other Unusual Items
10.6311.2826.0318.3618.2523.81
Pretax Income
100.26169.6403.02576.38838.071,031
Income Tax Expense
35.337.8160.2110.46124.05138.49
Net Income
64.97131.79342.82465.92714.02892.49
Net Income to Common
64.97131.79342.82465.92714.02892.49
Net Income Growth
-63.49%-61.56%-26.42%-34.75%-20.00%-2.80%
Shares Outstanding (Basic)
409412413416418381
Shares Outstanding (Diluted)
409412413416418381
Shares Change
-0.95%-0.29%-0.71%-0.37%9.48%1.77%
EPS (Basic)
0.160.320.831.121.712.34
EPS (Diluted)
0.160.320.831.121.712.34
EPS Growth
-63.14%-61.45%-25.89%-34.50%-26.92%-4.49%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
193.5832.78138.48125.0234.89-1.97
Free Cash Flow Per Share
0.470.080.340.300.08-0.01
Dividend Per Share
0.1000.1000.8000.8001.0001.000
Dividend Growth
-87.50%-87.50%0%-20.00%0%-
Gross Margin
67.95%70.81%80.95%80.43%86.60%89.45%
Operating Margin
0.32%4.13%22.96%28.84%40.51%47.41%
Profit Margin
4.86%9.48%20.45%26.62%39.34%42.74%
Free Cash Flow Margin
14.47%2.36%8.26%7.14%1.92%-0.09%
EBITDA
176.32227.46552.31624.89851.421,101
EBITDA Margin
13.18%16.36%32.95%35.71%46.91%52.73%
D&A For EBITDA
172.05170.1167.51120.24116.19111.07
EBIT
4.2757.36384.8504.66735.23990.02
EBIT Margin
0.32%4.13%22.96%28.84%40.51%47.41%
Effective Tax Rate
35.21%22.30%14.94%19.16%14.80%13.43%
Revenue as Reported
1,3381,3901,6761,7501,8152,088